Study of antibiotic resistance in freshwater ecosystems with low anthropogenic impact.

This study aimed to investigate the bacterial diversity and the background level of antibiotic resistance in two freshwater ecosystems with low anthropogenic impact in order to evaluate the presence of natural antimicrobial resistance in these areas and its potential to spread downstream. Water samples from a pre-Alpine and an Apennine river (Variola and Tiber, respectively) were collected in three different sampling campaigns and bacterial diversity was assessed by 16S sequencing, while the presence of bacteria resistant to five antibiotics was screened using a culturable approach. Overall bacterial load was higher in the Tiber River compared with the Variola River. Furthermore, the study revealed the presence of resistant bacteria, especially the Tiber River showed, for each sampling, the presence of resistance to all antibiotics tested, while for the Variola River, the detected resistance was variable, comprising two or more antibiotics. Screening of two resistance genes on a total of one hundred eighteen bacterial isolates from the two rivers showed that blaTEM, conferring resistance to ß-lactam antibiotics, was dominant and present in ~58 % of isolates compared to only ~9 % for mefA/E conferring resistance to macrolides. Moreover, ß-lactam resistance was detected in various isolates showing also resistance to additional antibiotics such as macrolides, aminoglycosides and tetracyclines. These observations would suggest the presence of co-resistant bacteria even in non-anthropogenic environments and this resistance may spread from the environment to humans and/or animals.

Repair of Irregularly Irregular Astigmatism by Transepithelial Phototherapeutic Keratectomy.

PURPOSE: To evaluate the outcome of transepithelial phototherapeutic keratectomy (PTK) in the management of irregularly irregular astigmatism. METHODS: This was a case series of two patients who underwent transepithelial PTK for irregularly irregular astigmatism. In the first case, the patient complained of diplopia due to corneal scarring caused by a metallic foreign body injury. The topography demonstrated irregularly irregular astigmatism with significant asymmetry in the inferotemporal to superonasal axis. In the second case, the patient complained of blurred vision and ghosting caused by significant central epithelial ingrowth through a buttonhole LASIK flap, which was causing a localized irregularity on topography. Due to the localized nature of the irregularities, a transepithelial PTK treatment was preferred to custom ablation given the degree of epithelial masking present. RESULTS: Transepithelial PTK was performed in both cases using the Schwind Amaris 500E excimer laser (Schwind eye-tech-solutions, Kleinostheim, Germany) and an 8-mm optical zone. The ablation depth was planned to reach the depth of the epithelium using a stepwise protocol, reviewing the pattern of the remaining epithelium and regularity of the stromal surface between each ablation. A marked improvement in the regularity of the topography was achieved in both cases, with only regular astigmatism remaining. Both patients reported a subjective improvement in quality of vision and the corrected distance visual acuity improved by one and two lines, respectively. CONCLUSIONS: Transepithelial PTK was effective in treating these cases of localized irregularly irregular astigmatism, achieving both objective and subjective improvement in vision. Compensatory epithelial remodeling over the irregularities enabled the transepithelial PTK approach to target the stromal surface irregularities. [J Refract Surg. 2017;33(10):714-719.].

Correction of postkeratoplasty ametropia in keratoconus patients using a toric implantable Collamer lens.

PURPOSE: To evaluate the efficacy and safety of a toric implantable Collamer lens (Visian TICL®) for correction of high postkeratoplasty ametropia in patients with keratoconus. 
 METHODS: Seven eyes of 7 keratoconus patients postkeratoplasty (5 M, 2 F; mean age 34.1±5.9 years, range 28-44) unable to wear glasses or contact lenses were included in the study. A foldable phakic posterior chamber Collamer toric lens was injected through a standard 3.0-mm clear corneal temporal incision. Uncorrected distance visual acuity (UCDVA, logMAR), best-corrected distance visual acuity (BCDVA, logMAR), spherical refraction, cylindrical refraction, and refractive spherical equivalent (RSE) were measured preoperatively and postoperatively. Postoperative adverse events were recorded. 
 RESULTS: . The mean follow-up was 12.8±8.8 months (range 4-30). A significant (p<0.01) improvement was observed postoperatively in mean UCDVA (1.18±0.4 vs 0.2±0.1), spherical refraction (-5.89±3.43 vs 0.53±0.75), cylindrical refraction (-4.39±0.75 vs -1.74±0.84), and RSE (-8.09±3.77 vs -0.33±0.54). The BCDVA changes were not significant (0.09±0.11 vs 0.05±0.08). All patients gained ≥5 lines of UCDVA (average 7.6±1.9 lines). The number of patients with UCDVA ≥6/12 (0.3 logMAR) increased after surgery (0% vs 87.5%; p<0.01), while the number of patients with BCDVA ≥6/12 was unchanged (100% vs 100%; NS), with 0% (0/7) of patients losing ≥2 BCDVA lines. No complications were observed postoperatively. 
 CONCLUSIONS: Toric implantable Collamer lens was safe and effective in correcting postkeratoplasty myopia and astigmatism in keratoconus patients.

Atopic keratoconjunctivitis and atopic dermatitis.

PURPOSE OF REVIEW: This review will focus on the diagnostic features of atopic keratoconjunctivitis (AKC), its relationship to atopic dermatitis, the immunopathogenesis, and therapy, and will include strategies used for the management of severe disease unresponsive to conventional therapy. RECENT FINDINGS: Recent research has demonstrated the importance of various cytokines (IL-33), proteins (thymic stromal lymphopoetin) and effector cells (conjunctival epithelial cells, eosinophils and basophils) in the pathogenesis of chronic ocular inflammation. Current evidence supports the use of tacrolimus and cyclosporin A, topically or systemically, as well tolerated and effective steroid sparing agents. SUMMARY: Recalcitrant AKC may be a blinding condition. Understanding the immunopathogenesis of atopic dermatitis and AKC has already influenced therapy and is essential to the development of future immunomodulatory treatments. The successful management of AKC requires the use of topical cromones, antihistamines and calcineurin inhibitors. Severely affected patients also require systemic immunosuppressive therapy. The current challenge is to find more specific topical and systemic immunomodulatory therapies with a better side-effect profile.